Rasagiline Tartrate

酒石酸雷沙吉兰

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameRasagiline Tartrate
Drug Alias NameRANZAL
ClassificationSmall molecules
Mechanisms of ActionMonoamine oxidase inhibitors
TargetsMonoamine oxidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved DateN/A
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN04BD02
Related LinksN/A